Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28930111 | 0.90 | NPC1 (0.41) | NPC1RAB9AL3MBTL1TP53MMP13 | |
| SCHEMBL28661409 | 0.85 | NPC1 (0.35) | NPC1RAB9AL3MBTL1 | |
| SCHEMBL28666879 | 0.85 | NPC1 (0.40) | NPC1RAB9AL3MBTL1MMP13 | |
| SCHEMBL28663864 | 0.84 | NPC1 (0.46) | NPC1RAB9AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL28688187 | 0.80 | NPC1 (0.47) | NPC1RAB9AL3MBTL1 | |
| SCHEMBL28670961 | 0.79 | MMP13 (0.33) | NPC1RAB9AL3MBTL1MMP13 | |
| SCHEMBL18342204 | 0.78 | RET (0.46) | — | |
| SCHEMBL20660263 | 0.78 | RAB9A (0.46) | NPC1RAB9AL3MBTL1ALDH1A1MAPT | |
| SCHEMBL18342474 | 0.78 | RET (0.46) | — | |
| SCHEMBL25256941 | 0.77 | NPC1 (0.51) | NPC1RAB9AL3MBTL1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107922394-B | 3-tetrazolyl-benzene-1, 2-disulfonamide derivatives as metallo-beta-lactamase inhibitors | 默沙东公司 | 2021-07-13 | — | — | CN | disclosed |